Rising premiums have driven a steady decline in employer-sponsored health insurance since 2000, according to a Robert Wood Johnson Foundation study released today.
In 2011, the number of Americans with employer-sponsored insurance stood at 159 million, a decline of 11.5 million from 2000. The 2011 figure represented 59.5% of the U.S. population, a drop of 10 percentage points from a decade earlier.
According to the report, 47 states had a statistically significant decline in employer-sponsored coverage from 2000-2011, with 22 states experiencing declines of at least 10 percentage points.
Read the full story: http://bit.ly/10YOCEs
Source: Modern Healthcare
Michigan saw the biggest percentage drop—15.2 percentage points—over the period, while North Dakota saw the smallest drop, less than one percentage point.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More